Company Filing History:
1 out of 176 
1 out of 8 Years Active: 2023
Title: Shirin Jamshidi: Innovator in Antibiotic Resistance Solutions
Introduction
Shirin Jamshidi is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceuticals, particularly in developing solutions to combat antibiotic resistance. Her innovative work focuses on creating compounds that can effectively treat drug-resistant bacterial infections.
Latest Patents
Shirin Jamshidi holds a patent for antibiotic resistance breakers. The invention relates to antibiotic compounds of formula (A1) and pharmaceutically acceptable salts, solvates, tautomers, and combinations thereof. In this formula, X and L are optional linkers, and one of R or R comprises Ar, where Ar is an antibiotic resistance breaker moiety. This moiety includes an optionally substituted Caryl, Caralkyl, Cheteroaryl, Cheteroaralkyl, Cheterocyclyl, Cheterocyclalkyl, Ccarbocyclyl, Ccarbocyclalkyl, —C(═NR')—NR′R″ or —CH—CH═CH group. After administration of the compound to a bacterial infection, this moiety reduces or prevents efflux. The invention also discloses pharmaceutical compositions comprising compounds of formula (A1) and their use as medicaments, particularly for treating bacterial infections, including drug-resistant bacterial infections.
Career Highlights
Throughout her career, Shirin has worked with notable institutions, including King's College London and the Secretary of State for Health and Social Care. Her work has been instrumental in advancing research and development in the field of antibiotic resistance.
Collaborations
Shirin has collaborated with esteemed colleagues such as Khondaker Mirazur Rahman and Mark Benjamin Laws. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Shirin Jamshidi is a trailblazer in the fight against antibiotic resistance, with her innovative patents and collaborations paving the way for future advancements in medical treatments. Her contributions are vital in addressing one of the most pressing challenges in healthcare today.